{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:28:03Z","timestamp":1716942483104},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deputy of research and technology at Shahid Beheshti University of Medical Sciences","award":["23920","23920","23920","23920","23920","23920"],"award-info":[{"award-number":["23920","23920","23920","23920","23920","23920"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Disease registries are comprehensive databases that record detailed information on patients diagnosed with specific conditions, providing valuable insights into their diagnosis, treatment, and outcomes. This study aims to describe the pilot phase of the national pediatric Immune Thrombocytopenia(ITP) registry (NPITP) in Iran, serving as the inaugural interpretive report.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This patient-centered software system was implemented as a national program across multiple pediatric centers in Iran. Several focus groups were conducted to establish a minimum data set (MDS) comprising six main classes, 14 sub-classes, and 187 data elements. Following expert consensus on the final data set, a web-based software tool was developed by the dedicated IT team, accessible online and offline via <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/disreg.sbmu.ac.ir\/q\/ITP.html\">https:\/\/disreg.sbmu.ac.ir\/q\/ITP.html<\/jats:ext-link>. The registry included children aged between two months and 18 years with a platelet count below 100\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L, based on predefined inclusion criteria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Within a four-month period, a total of 60 ITP patients were registered, including 41 (68.3%) newly diagnosed cases, 68 (13.6%) persistent cases, and 14 (23.3%) with chronic ITP. The mean age of the registered patients was 55.93\u2009\u00b1\u20099.72 months. The most frequently observed bleeding symptoms were petechiae (68.3%), purpura (51.6%), and ecchymosis (13.3%). Among the newly diagnosed patients, 20 (33.3%) received intravenous immunoglobulin (IVIG), 17 (28.3%) were treated with prednisolone, and 17 (28.3%) received combined IVIG and steroid therapy. Of all patients, 40 (66.7%) demonstrated a complete response to treatment, while 16 (26.7%) exhibited a partial response. Four patients (6.7%) remained unresponsive to therapy. Treatment-related complications, such as Cushing\u2019s syndrome, edema, weight gain, hirsutism, and mood disorders, were reported in 10 patients (16.6%). However, the majority of patients (81.7%) did not experience therapy-related complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The pilot phase of the NPITP registry successfully implemented a web-based software tool for data collection, aiming to enhance the quality of care, facilitate clinical research, and support health service planning in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-024-11102-z","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T22:01:59Z","timestamp":1716933719000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The first national pediatric immune thrombocytopenia registry in Iran: research protocol and preliminary study results"],"prefix":"10.1186","volume":"24","author":[{"given":"Sharareh","family":"Kamfar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahat","family":"Haghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahide","family":"Zeinali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parastoo Molaei","family":"Tavana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Arjmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Malek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"issue":"3","key":"11102_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ajh.21616","volume":"85","author":"DR Terrell","year":"2010","unstructured":"Terrell DR, Beehnbe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85(3):174\u201380.","journal-title":"Am J Hematol"},{"issue":"23","key":"11102_CR2","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1182\/blood.V126.23.3478.3478","volume":"126","author":"J Lakhani","year":"2015","unstructured":"Lakhani J, Klaassen RJ, Barrowman NJ, Chan J, Grainger JD. Second line ITP therapy in the UK: results from the UK Paediatric ITP Registry. Blood. 2015;126(23):3478.","journal-title":"Blood"},{"issue":"8","key":"11102_CR3","first-page":"442","volume":"18","author":"JM Cunningham","year":"2020","unstructured":"Cunningham JM. Updated recommendations for the treatment of immune thrombocytopenia. Clin Adv Hematol Oncology: H&O. 2020;18(8):442\u20136.","journal-title":"Clin Adv Hematol Oncology: H&O"},{"issue":"3","key":"11102_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/pbc.20453","volume":"46","author":"P Imbach","year":"2006","unstructured":"Imbach P, K\u00fchne T, M\u00fcller D, Berchtold W, Zimmerman S, Elalfy M, et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer. 2006;46(3):351\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"11102_CR5","first-page":"2386","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood J Am Soc Hematol. 2009;113(11):2386\u201393.","journal-title":"Blood J Am Soc Hematol"},{"issue":"2","key":"11102_CR6","first-page":"168","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood J Am Soc Hematol. 2010;115(2):168\u201386.","journal-title":"Blood J Am Soc Hematol"},{"issue":"23","key":"11102_CR7","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829\u201366.","journal-title":"Blood Adv"},{"issue":"5","key":"11102_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/MOH.0b013e3282ab98c7","volume":"14","author":"PF Fogarty","year":"2007","unstructured":"Fogarty PF, Segal JB. The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol. 2007;14(5):515\u20139.","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"11102_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2326-12-2","volume":"12","author":"TM Brown","year":"2012","unstructured":"Brown TM, Horblyuk RV, Grotzinger KM, Matzdorff AC, Pashos CL. Patient-reported treatment burden of chronic immune thrombocytopenia therapies. BMC Blood Disorders. 2012;12(1):1\u20138.","journal-title":"BMC Blood Disorders"},{"key":"11102_CR10","doi-asserted-by":"crossref","unstructured":"George J, Woolf S, Raskob G, Wasser J, Aledort L, Ballem P et al. War\u2009\u2013\u2009rier I: idiopathic thrombocytopenic purpura: apractice guideline developed by explicit method for the American Society of Hematology. Blood. 1996;88.","DOI":"10.1182\/blood.V88.1.3.3"},{"issue":"10","key":"11102_CR11","first-page":"539","volume":"29","author":"KA LaBresh","year":"2003","unstructured":"LaBresh KA, Gliklich R, Liljestrand J, Peto R, Ellrodt AG. Using get with the guidelines to improve cardiovascular secondary prevention. Joint Comm J Qual Saf. 2003;29(10):539\u201350.","journal-title":"Joint Comm J Qual Saf"},{"issue":"1","key":"11102_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","volume":"88","author":"JN George","year":"1996","unstructured":"George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88(1):3\u201340.","journal-title":"Blood"},{"issue":"S1","key":"11102_CR13","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/pbc.24342","volume":"60","author":"T K\u00fchne","year":"2013","unstructured":"K\u00fchne T. Update on the intercontinental cooperative ITP study group (ICIS) and on the pediatric and adult registry on chronic ITP (PARC ITP). Pediatr Blood Cancer. 2013;60(S1):S15\u20138.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"11102_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/bjh.18111","volume":"197","author":"G Moulis","year":"2022","unstructured":"Moulis G, Cooper N, Ghanima W, Gonz\u00e1lez-L\u00f3pez T, K\u00fchne T, Lozano ML, et al. Registries in immune thrombocytopenia (ITP) in Europe: the European Research Consortium on ITP (ERCI) network. Br J Haematol. 2022;197(5):633\u20138.","journal-title":"Br J Haematol"},{"issue":"1","key":"11102_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.oncohp.2014.12.006","volume":"3","author":"M Pasquet","year":"2015","unstructured":"Pasquet M, Aladjidi N, Guitton C, Leblanc T, P\u00e9rel Y, Leverger G. Recommandations d\u2019utilisation des agonistes du r\u00e9cepteur de la thrombopo\u00ef\u00e9tine dans le purpura thrombop\u00e9nique immunologique de l\u2019enfant et de l\u2019adolescent. Revue d\u2019Oncologie H\u00e9matologie P\u00e9diatrique. 2015;3(1):4\u201312.","journal-title":"Revue d\u2019Oncologie H\u00e9matologie P\u00e9diatrique"},{"issue":"1","key":"11102_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/adc.2010.184234","volume":"97","author":"JD Grainger","year":"2012","unstructured":"Grainger JD, Rees JL, Reeves M, Bolton-Maggs PH. Changing trends in the UK management of childhood ITP. Arch Dis Child. 2012;97(1):8\u201311.","journal-title":"Arch Dis Child"},{"issue":"1","key":"11102_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0197-2456(86)90005-X","volume":"7","author":"A Bagniewska","year":"1986","unstructured":"Bagniewska A, Black D, Molvig K, Fox C, Ireland C, Smith J, et al. Data quality in a distributed data processing system: the SHEP pilot study. Control Clin Trials. 1986;7(1):27\u201337.","journal-title":"Control Clin Trials"},{"issue":"2","key":"11102_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/sim.4780030204","volume":"3","author":"YN Marinez","year":"1984","unstructured":"Marinez YN, McMahan CA, Barnwell GM, Wigodsky HS. Ensuring data quality in medical research through an integrated data management system. Stat Med. 1984;3(2):101\u201311.","journal-title":"Stat Med"},{"key":"11102_CR19","volume-title":"Standardization of patient registries for improved data collection and outcome measurement. NI 2012: 11th International Congress on Nursing Informatics, June 23\u201327, 2012","year":"2012","unstructured":"Spisla CM, Lundberg CB, editors. Standardization of patient registries for improved data collection and outcome measurement. NI 2012: 11th International Congress on Nursing Informatics, June 23\u201327, 2012. Montreal, Canada: American Medical Informatics Association; 2012."},{"key":"11102_CR20","unstructured":"Gliklich RE, Dreyer NA, Leavy MB. Registries for evaluating patient outcomes: a user\u2019s guide. 2014."},{"key":"11102_CR21","unstructured":"Preamble I. American College of Epidemiology. 2002."},{"issue":"6","key":"11102_CR22","first-page":"1231","volume":"113","author":"R Stasi","year":"2009","unstructured":"Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood J Am Soc Hematol. 2009;113(6):1231\u201340.","journal-title":"Blood J Am Soc Hematol"},{"key":"11102_CR23","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2147\/IJGM.S290459","volume":"13","author":"Y Sun","year":"2020","unstructured":"Sun Y, Long S, Liu W. Risk factors and psychological analysis of chronic immune thrombocytopenia in children. Int J Gen Med. 2020;13:1675.","journal-title":"Int J Gen Med"},{"issue":"7","key":"11102_CR24","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1182\/blood-2004-12-4598","volume":"106","author":"DB Cines","year":"2005","unstructured":"Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood. 2005;106(7):2244\u201351.","journal-title":"Blood"},{"issue":"10","key":"11102_CR25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s12098-013-1217-2","volume":"81","author":"D Bansal","year":"2014","unstructured":"Bansal D, Rajendran A, Singhi S. Newly diagnosed immune thrombocytopenia: update on diagnosis and management. Indian J Pediatr. 2014;81(10):1033\u201341.","journal-title":"Indian J Pediatr"},{"issue":"12","key":"11102_CR26","first-page":"1358","volume":"64","author":"N Mushtaq","year":"2014","unstructured":"Mushtaq N, Alam M, Fadoo Z. Idiopathic thrombocytopenic purpura in children: a 10 years\u2019 experience at tertiary care hospital. J Pak Med Assoc. 2014;64(12):1358\u201362.","journal-title":"J Pak Med Assoc"},{"issue":"24","key":"11102_CR27","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1182\/bloodadvances.2017009860","volume":"1","author":"CE Neunert","year":"2017","unstructured":"Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Blood Adv. 2017;1(24):2295\u2013301.","journal-title":"Blood Adv"},{"issue":"8232","key":"11102_CR28","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","volume":"317","author":"P Imbach","year":"1981","unstructured":"Imbach P, d\u2019Apuzzo V, Hirt A, Rossi E, Vest M, Barandun S, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981;317(8232):1228\u201331.","journal-title":"Lancet"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-024-11102-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-024-11102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T22:02:53Z","timestamp":1716933773000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-024-11102-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["11102"],"URL":"https:\/\/doi.org\/10.1186\/s12913-024-11102-z","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"17 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Given the registry nature of our study, involving solely data registration without participant interaction, consent was considered unnecessary. All the procedures performed in the study were approved by Ethics Committee of Shahid Beheshti University of Medical Sciences (IR.SBMU.RICH.REC.1399.021) and the 1964 Helsinki declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"675"}}